Browse 26479 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| March 9th, 2023 |
HEAL Initiative: Discovery and Functional Evaluation of Human Pain-associated Genes and Cells (U19 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 13th, 2023 |
Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed) |
National Institutes of Health |
| September 25th, 2024 |
NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 17th, 2024 |
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 17th, 2024 |
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed) |
National Institutes of Health |
| May 23rd, 2022 |
Transforming Pediatrics for Early Childhood (TPEC) |
Health Resources and Services Administration |
| January 25th, 2025 |
NHGRI Short Courses for Genomics-Related Research Education (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
| April 18th, 2022 |
Integrative Research in Gynecologic Health (R01 Clinical Trial Optional) |
National Institutes of Health |
| February 11th, 2022 |
Strategic Project for Epidemic Control of Key Populations |
South Africa USAID Pretoria |
| December 23rd, 2022 |
Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Optional) |
National Institutes of Health |
| December 23rd, 2022 |
Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Required) |
National Institutes of Health |
| February 25th, 2022 |
Improving Quality of Healthcare (IQH) |
Ethiopia USAID Addis Ababa |
| April 7th, 2022 |
Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R21 Clinical Trial Optional) |
National Institutes of Health |
| April 26th, 2022 |
Enhanced surveillance of persons with early and late HIV diagnosis to understand system and individual factors associated with new infection and delayed testing |
Centers for Disease Control NCHHSTP |
| April 7th, 2022 |
Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R01 Clinical Trial Required) |
National Institutes of Health |
| June 24th, 2022 |
Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional) |
National Institutes of Health |
| April 7th, 2022 |
Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional) |
National Institutes of Health |
| June 7th, 2024 |
BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
| February 28th, 2022 |
Investigation of Monkeypox and Other Zoonotic Diseases in the Democratic Republic of the Congo (DRC) |
Centers for Disease Control and Prevention ERA |
| December 20th, 2024 |
Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed) |
National Institutes of Health |
|
| December 20th, 2024 |
Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed) |
National Institutes of Health |
| December 20th, 2024 |
Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials |
National Institutes of Health |
| October 9th, 2024 |
NIMH Instrumentation Program (S10 Clinical Trial Not Allowed) |
National Institutes of Health |
| December 20th, 2024 |
Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) |
National Institutes of Health |
| December 20th, 2024 |
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) |
National Institutes of Health |
| June 17th, 2022 |
ARDS, Pneumonia, and Sepsis Phenotyping Consortium Coordinating Center (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| June 17th, 2022 |
ARDS, Pneumonia, and Sepsis Phenotyping Consortium Clinical Centers (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 18th, 2022 |
Advancing Research on Mechanisms and Management of Pain for Diseases and Conditions within NIDDK Mission Areas (R01 Clinical Trial Optional) |
National Institutes of Health |
| March 18th, 2022 |
Emergency Award HEAL Initiative: Developing and Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional) |
National Institutes of Health |
| March 18th, 2022 |
Emergency Award HEAL Initiative: Optimizing Existing Evidence-Based Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials |
National Institutes of Health |
| June 14th, 2024 |
BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| May 7th, 2025 |
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) |
National Institutes of Health |
| March 28th, 2022 |
Connecting Kids to Coverage HEALTHY KIDS 2022 Outreach and Enrollment Cooperative Agreements |
Centers for Medicare Medicaid Services |
| March 31st, 2022 |
HEAL Initiative: Secondary Analysis and Integration of Existing Data Related to Acute and Chronic Pain Development or Management in Humans (R21 Clinical Trials Not Allowed) |
National Institutes of Health |
| May 1st, 2023 |
Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed) |
National Institutes of Health |
| June 9th, 2022 |
Revolutionizing Innovative, Visionary Environmental Health Research (RIVER) (R35 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2025 |
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| December 4th, 2024 |
Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (UT1/UT2 Clinical Trial Optional) |
National Institutes of Health |
| May 22nd, 2023 |
Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed) |
National Institutes of Health |
| July 1st, 2023 |
Genome Research Experiences to Attract Talented Undergraduates into Genomic Fields to Enhance Diversity (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
